Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity

NCT05933499 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Bimagrumab
DRUG: Tirzepatide
DIETARY_SUPPLEMENT: Calcium/Vitamin D
BEHAVIORAL: Lifestyle and nutrition counseling

Sponsor

Massachusetts General Hospital